We also observed that five days of treatment with a Th2 cytokine implicated in nasal polyp inflammation, IL-13 [41,42], markedly down-regulated cilia-localized T2R4, 14, and 38 expression in well-differentiated (day 21) nasal ALIs (Figure 3B). The gene discussed is IL13; the disease is nasal cavity polyp.